News Focus
News Focus
icon url

KRISGO

03/10/25 7:25 PM

#753471 RE: Investor082 #753468

A company that was serious would have also submitted to another regulatory agency such as FDA and EU. Again, the trial got over 4.5 years ago, but no guidance on US application. US is 20 X of UK in terms of revenue potential. US represents over 50% of the world’s revenue in oncology therapies.


One reason could be that they're understaffed and unable to handle both agencies at the same time. They might want to move forward with the next steps, thinking that MHRA approval will improve their chances with various agencies and approvals. One thing is certain: all of us—investors and patients—have lost out on the vaccine due to these delays.
icon url

SkyLimit2022

03/10/25 7:30 PM

#753472 RE: Investor082 #753468

zero82,

Thanks for reposting that again 😶

Yes, “relentless execution” …



✅️ She executed her plan to acquire, develop, and secure a valuable patent-fortified manufacturing technology called EDEN. (Flaskworks strategic acquisition was relatively recent in 2020).

✅️ She executed her plan to get a prestigious and reputable medical journal to publish an independently peer-reviewed analysis of the P3.

✅️ She executed her plan to acquire the commercial rights to ANOTHER patent-fortified novel dendritic cell technology that’s in PII trials funded by the U.S. DoD at Roswell Park.

✅️ She executed her plan to recruit Linda Liau to join the SAB at NWBO.

✅️ She executed her plan to secure a PIP approval and an MIA approval from MHRA followed by a voluminous MAA submission.

✅️ She executed her plan to recruit Dr. Ashkan to run the DCVax-L trial in Europe and lead the UK Specials Program that has the ongoing support of the MHRA.




“His work on brain cancer vaccines received the top presentation award by the British Neuro-Oncology Society in 2022 and promises to impact the care of patients with brain tumours worldwide.”

https://thejns.org/caselessons/view/journals/j-neurosurg-case-lessons/8/2/article-CASE24112.xml

https://www.kcl.ac.uk/news/professor-keyoumars-ashkan-awarded-mbe-in-kings-new-years-honours

https://www.bbc.com/news/uk-england-london-66378288

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175903429
Bullish
Bullish
icon url

theorysuit

03/10/25 9:59 PM

#753479 RE: Investor082 #753468

Data lock was over 4.5 years ago but the trial was over 8 years ago. This is the world record.....this is what happens when ceco priorities are building out her own CDMO(s) x 2.

You know you made it when you have an AI troll responding to your every post. Gotta keep truth from coming out by drowning you out.
icon url

XMaster2023

03/11/25 8:38 AM

#753508 RE: Investor082 #753468

If you had a cancer diagnosis, you’d not be asking such a stupid question. It’s coming and Karma’s a bitch.